Literature DB >> 24042326

Diabetes: Clinical inertia--a barrier to effective management of T2DM.

Julie A Lovshin1, Bernard Zinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24042326     DOI： 10.1038/nrendo.2013.185

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Prevalence of obesity in the United States, 2009-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  NCHS Data Brief       Date:  2012-01

Review 3.  Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time?

Authors:  Bernard Zinman
Journal:  Am J Med       Date:  2011-01       Impact factor: 4.965

4.  Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

Authors:  Baiju R Shah; Janet E Hux; Andreas Laupacis; Bernard Zinman; Carl van Walraven
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

5.  Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

Authors:  Alice Y Y Cheng
Journal:  Can J Diabetes       Date:  2013-03-26       Impact factor: 4.190

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

Review 8.  Management of type 2 diabetes: new and future developments in treatment.

Authors:  Abd A Tahrani; Clifford J Bailey; Stefano Del Prato; Anthony H Barnett
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

9.  Multidrug treatment of type 2 diabetes: a challenge for compliance.

Authors:  Roberto Miccoli; Giuseppe Penno; Stefano Del Prato
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

10.  Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.

Authors:  Kamlesh Khunti; Michael L Wolden; Brian Larsen Thorsted; Marc Andersen; Melanie J Davies
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112
  10 in total
  8 in total

1.  Assessing the Effect of Clinical Inertia on Diabetes Outcomes: a Modeling Approach.

Authors:  Maria F Correa; Yan Li; Hye-Chung Kum; Mark A Lawley
Journal:  J Gen Intern Med       Date:  2018-12-18       Impact factor: 5.128

2.  Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Authors:  Josep Franch-Nadal; Fermín García-Gollarte; Alfonso Pérez Del Molino; María L Orera-Peña; Marta Rodríguez de Miguel; Malena Melogno-Klinkas; Héctor D de Paz; Susana Aceituno; Patricia Rodríguez-Fortúnez
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

3.  Use of an Electronic Medical Record (EMR) to Identify Glycemic Intensification Strategies in Type 2 Diabetes.

Authors:  Mary T Korytkowski; Maria Brooks; Manuel Lombardero; Dilhari DeAlmeida; Justin Kanter; Vasudev Magaji; Trevor Orchard; Linda Siminerio
Journal:  J Diabetes Sci Technol       Date:  2014-12-18

4.  Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?

Authors:  William David Strain; Matthias Blüher; Païvi Paldánius
Journal:  Diabetes Ther       Date:  2014-08-12       Impact factor: 2.945

5.  Efficacy and safety of metformin and sitagliptin-based dual and triple therapy in elderly Chinese patients with type 2 diabetes: Subgroup analysis of STRATEGY study.

Authors:  Xiangyang Liu; Li Wang; Ying Xing; Samuel S Engel; Longyi Zeng; Bin Yao; Wen Xu; Guojuan Chen; Ye Zhang; Ruya Zhang; Shu Liu; Jianping Weng; Qiuhe Ji
Journal:  J Diabetes Investig       Date:  2020-06-01       Impact factor: 4.232

6.  Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital.

Authors:  Sun Joon Moon; Hun Jee Choe; Soo Heon Kwak; Hye Seung Jung; Kyong Soo Park; Young Min Cho
Journal:  Diabetes Metab J       Date:  2021-10-20       Impact factor: 5.893

7.  Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.

Authors:  Lori Berard; Noreen Antonishyn; Kathryn Arcudi; Sarah Blunden; Alice Cheng; Ronald Goldenberg; Stewart Harris; Shelley Jones; Upender Mehan; James Morrell; Robert Roscoe; Rick Siemens; Michael Vallis; Jean-François Yale
Journal:  Diabetes Ther       Date:  2018-02-23       Impact factor: 2.945

8.  Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income country.

Authors:  Marcelo Alves Alvarenga; William Ricardo Komatsu; Joao Roberto de Sa; Antonio Roberto Chacra; Sergio Atala Dib
Journal:  Diabetol Metab Syndr       Date:  2018-10-29       Impact factor: 3.320
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.